A cross-border venture capital firm headquartered in Asia with USA offices, with a recently launched incubator business, typically makes an initial investment ranging from under $1 million to $3-6 million dependent on the company’s stage of development. The firm can allocate up to $16 million over the lifetime of a company. The firm invests in early-stage therapeutic companies worldwide.
The firm only invests in therapeutics, and are primarily focused on companies with preclinical or clinical assets. Within therapeutics, all modalities are of interest. The firm may invest up to 18 months prior to IND, however require that a company has a lead asset that has been characterized. The firm will consider opportunities in any indication area.
The firm invests in teams with experienced, highly motivated teams with a strong background in either life science research or industry. The firm only invests in companies with technology that has the potential to be first in class.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.
Category: Redefining Every Stage Investments (RESI)
The Redefining Every Stage Investments (RESI) Conference is an ongoing conference series that provides an international venue for life science companies across Biotech, Medtech, Diagnostics and Healthcare IT and to source investors from around the globe, create relationships, and eventually, secure funding.
Hot Investor Mandate: Asia-Based Firm With Large Hospital Network Invests in Digital Health Companies Seeking to Expand into Asian Markets
A firm that operates a large hospital network across Asia and the Middle East has an innovation office that acts as a corporate VC arm, which has committed capital of $80 million to invest in the digital health space. The firm typically invests $5-10 million per opportunity, and will invest in companies worldwide that are interested in expanding into Asia.
The firm only invests in the digital health space. The firm is interested in many areas of digital health, diagnostics, and tech-enabled healthcare services, including wellness, digital therapeutics, AI, healthcare data, remote monitoring, chronic disease management, etc. The firm does not invest in biopharma or medtech.
The firm will invest globally, and is focused on startups that are interested in expanding into Asia.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.
Automating Medical Visits Using Artificial Intelligence (AI) and Augmented Reality (AR) – Interview with James Bates, MS, CEO of AdviNOW Medical
By Erika Wu, Business Development Representative, LSN
What if we could automate and improve medical visits by reducing in-person patient contact, administrative burdens and operation costs? Hear what CEO James Bates and his team at AdviNOW Medical are doing to utilize AR and AI to expand healthcare access to anywhere you are. RESI AI returns September 16-17 with dynamic panels, as well as opportunities to pitch to a live panel of AI investors. Get involved and tell your story at Innovator’s Pitch Challenge! Applications are due by Friday, August 20, so submit yours today!
September Partnering Opens Soon
By Karen Deyo, Director of Investor Research, Israel BD, LSN
Life Science Nation (LSN)’s mission is to connect products, services, and capital to advance deals that save lives. There are many opportunities to achieve this in the early-stage life science ecosystem, but few more powerful than well-matched partnering, which is why LSN’s match-based partnering platform can be a game-changer for fundraising entrepreneurs.
Learn more about virtual partnering at LSN events at one of our free fundraising bootcamps coming up on Wednesday, August 18 at 2 PM EDT. Register here for the complimentary webinar. These events give an overview of LSN’s partnering system, what sets it apart, and why a comprehensive strategy is essential to succeed in booking meetings with qualified investors.
Check out some of our resources below to help you succeed in your partnering, and sign up for our one-day prep course ahead of RESI Partnering Week, September 13-17 to get started!
Pitch Deadline Approaching
By Rory McCann, Marketing Manager & Conference Producer, LSN
The application deadline to pitch at RESI Partnering Week, September 13-17 is around the corner. Submit your application to pitch directly to a panel of relevant investors by August 20. Applications are accepted on a rolling basis.
The Innovator’s Pitch Challenge (IPC) provides an opportunity for life science startups to pitch directly to a panel of investors during a live Q&A session, providing valuable insights and feedback. Participants build connections between fundraising founders and potential investors on the panel and in the audience.
Participating companies receive:
- A dedicated page showcasing a pre-recorded pitch video, pitch deck, and executive summary
- A spot in the live pitch session and Q&A with investors actively seeking assets in their sector
- Global visibility to partners that are a fit for their stage of development and product
- Increased global footprint, opportunities to engage with global partners, and valuable, insightful feedback
Hear from recent IPC winners, see what investors have to say, and sign up today to pitch at RESI Partnering Week!
See What Investors Are Saying about The Innovator’s Pitch Challenge
|
William Kuziel, MedPro Investors
Mayank Taneja, OSF Healthcare
Nat Brinn, VC23
Gary Gershony, Life Science Angels / BayMed Venture Partners
|
RESI Longevity Panels
By Caitlin Dolegowski, Marketing Specialist, LSN
RESI Longevity is proud to highlight active investors, early-stage founders, and industry leaders advancing drugs, devices, diagnostics, and digital health within age-tech and the longevity market. Innovative advancements with creative applications take center stage alongside insights around how to navigate the early-stage investment ecosystem.
Lifes Science Nation has partnered with Mary Furlong & Associates to host panel discussions with leaders, entrepreneurs, and strategic partners answering questions about early-stage fundraising and age-tech innovation. Check out the panel discussions below and sign up to join the conversation at digital RESI Longevity.
| September 16, 2021 Live Panels | |
| Social Isolation & Loneliness Enabling Seniors to Connect & Thrive in Relationships |
10 AM EDT |
| The effects of social isolation and loneliness brought about by the COVID-19 global pandemic has been devastating to many communities. Connection and community are essential to health and wellbeing, especially for vulnerable populations, including seniors. This panel highlights not only the need to advance this area of healthcare, but the partnerships bringing people together, through powerful technology, when they need it most. | |
| Sensory Wellness Advancing Technology to Support Vision or Hearing Loss |
11 AM EDT |
| Whether a gradual decline or a sudden loss due to illness, the effects of vision and hearing impairment for older adults can be incredibly disruptive to their health and quality of life. Sensors, wearables, AI, and the continued advancement of diagnostic technology and digital health are impacting this field of care at a rapid rate. Targeting sensory wellness keeps seniors living active and engaged lifestyles, supporting a holistic approach to wellness. | |
| Designing Innovation in Assisted Living and Aging in Place | 3 PM EDT |
| The 2020 pandemic brought about transformational changes in how we look at aging and our living environments. Keeping loved ones safe and connected became top priorities but it also unleashed design innovations for aging in place and assisted living. This panel explores the trends and future view of how our health is connected to where we live. | |
| Creating Better Dementia Care and Promoting Brain Health | 4 PM EDT |
| Despite the coronavirus crisis, surveys show more older Americans were more concerned about an Alzheimer’s diagnosis than COVID-19. The U.S. health care system is still struggling with the need for not only better therapeutics and dementia care but also understanding the importance of prevention aligned with new brain health initiatives. This panel discusses the innovation in dementia care and brain health education for health care professionals and the broader population. | |
| September 17, 2021 Live Panels | |
| Health & Home Care Empowering Individuals to Access Quality Care from Home |
10 AM EDT |
| Quality home-based care can be a powerful tool in a patient’s recovery or ongoing wellness. Advancements designed to support and improve home care are a huge part of the age-tech industry and healthcare. Learn how entrepreneurs are partnering with investors to bring quality services from the provider to the patient at home. | |
| Medical Accountability & Adherence Removing Barriers Inhibiting Patients from Treatment |
11 AM EDT |
| Medical advancement is paramount to the health and safety of patients, but efficacy tanks when adherence is low. Seniors unable to take medication or easily access necessary information are at risk of missing out on necessary treatment. Early-stage entrepreneurs are using technology to advance systems designed to enable patients to better access their healthcare resources, including medication, providers, and treatment details. | |
| What Angels, Seed, Venture, Corporate and Family Offices Investors Are Looking For | 3 PM EDT |
| These investors talk about how to find the perfect funding partners – what entrepreneurs should look for and what to expect. This essential panel is a critical “how to” session for any startup company in the longevity market. | |
| Pre-Recorded Panel | |
| The Future of Wearables and Older Adults 2021 | |
| This session explores the growth of the wearables market (a $111B industry) and its meaning for older adults. What is the adoption level for the 65+ population now and what innovations will matter in the future? | |
The Business of Biotech: The Moexa Perspective
By Rory McCann, Marketing Manager & Conference Producer, LSN
Every startup operates according to the strengths of its leaders and partners, making it essential for successful companies to be built on the diverse skill sets of their teams. Former Innovation Challenge (now Innovator’s Pitch Challenge) winner, Moexa is a shining example of unique experiences and diverse skills put to the test and passing.
Moexa Director and CEO, Anthony Desir has had a successful career in finance and business development before leading the multi-national drug research and development company, and took the time to share his RESI experience, as well as the tools he’s utilized to lead Moexa and lessons he’s learned along the way. Listen to our conversation and sign up for RESI Partnering Week, September 13-17 to jumpstart your own early-stage fundraising journey. Early bird rates for RESI Partnering Week end Friday, August 6. Register today to save!





“The Pitch Sessions are a great opportunity to connect with startup CEOs and learn more about their work…It really has been an effective and efficient way to make connections, create deal flow and help startups raise money for their upcoming raises.”
“I look forward to LSN’s events because they provide an opportunity for our venture capital firm to find promising companies with exceptional technologies. The organization and technology platform make it very easy to hear numerous pitches from founders.”
“The Pitch Sessions were a great opportunity to engage with the CEO/Founders of very innovative Life Science startups. Despite the COVID-related transition from in-person to virtual meetings, the RESI team did an outstanding job organizing these sessions, ensuring that the live Q&A was very productive, and facilitating follow-up with these exciting companies.”